Nearly three of four US high school students report one or more adverse experiences contributing to poor mental health and suicidal behaviors amid the COVID-19 pandemic, according to a survey published today in Morbidity and Mortality Weekly Report (MMWR).
A new global estimate of people who experienced long-COVID symptoms after having symptomatic COVID infection suggests that 6.2% reported one of three long-term symptom clusters, an international research group reported yesterday in JAMA.
A US study of almost 17,000 patients finds modest two-dose Pfizer COVID vaccine effectiveness (VE) against hospitalization and emergency department (ED) admission for Omicron BA.1 (the original Omicron variant) and the BA.2 subvariant, but three-dose VE was 79% and 71% for hospitalization, respectively, and 72% and 21% for ED visits.
The US Centers for Disease Control and Prevention (CDC) urged clinicians to consider Ebola and other viral hemorrhagic fever illness in the workup of people who have symptoms of the diseases and to immediately take a travel history with an eye toward identifying those who have been in parts of Uganda affected by the recent Ebola Sudan outbreak.
So far 63 cases have been reported, including 29 deaths, and 10 healthcare workers have been infected.
Over the past 3 days, Uganda's health ministry has reported 8 more Ebola Sudan cases, along with 2 more deaths, with officials also announcing that a doctor is among the fatal cases.
Since the outbreak was first announced on Sep 20, Uganda continues to report a steady stream of new cases, but so far, the illnesses appear to be limited to hot spots in the west central part of the country near Mubende.
Uganda's health ministry on Twitter today reported four more lab-confirmed Ebola Sudan cases, as well as one more death in a patient with a confirmed infection. The developments push the country's overall total to 54 cases, 35 of them confirmed and 19 listed as probable. The latest death brings Uganda's fatality count to 25, 7 in confirmed patients and 18 in people who had probable infections.
Officials add 14 more cases to the total, and the fatality count rises to 24.
A report published yesterday in Clinical Infectious Diseases describes a new SARS-CoV-2 mutation that confers resistance to the COVID-19 antiviral drug remdesivir in two persistently infected kidney transplant recipients treated with immunosuppressive drugs.
Illnesses have been reported in 2 more locations.
